Tri-luma

   
Google
 
Web NewDrugInformation.com

Tri-luma


Drug - Tri-luma
The trade name of the product as shown on the labeling.

Dosage - CREAM; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Fluocinolone Acetonide; Hydroquinone; Tretinoin
Multiple ingredients are in alphabetical order.

Strength - 0.01%;4%;0.05%
The potency of the active ingredient(s), Fluocinolone Acetonide; Hydroquinone; Tretinoin. May repeat for multiple part products.

Applicant - GALDERMA LABS LP
The firm name holding legal responsibility for Tri-luma. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021112
The FDA assigned number to Tri-luma. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tri-luma. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 18, 2002
The date Tri-luma was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Tri-luma. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tri-luma is in. Format is RX, OTC, DISCN.

Applicant Full Name - Galderma Laboratories Lp
The full name of the firm holding legal responsibility for the new application of Tri-luma.

Tri-luma